Market Cap $ M 9.30
Enterprise Value $ M 54.49
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 30.90
Price/Sales 0.33
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) $ M 27.00
EPS (TTM) $ -1.63
Beneish M-Score -2.83
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % --
y-y EBITDA Growth Rate % --
EV-to-EBIT -1.22
EV-to-EBITDA -1.35
PEG --
Shares Outstanding M 30.10
Net Margin (%) -173.49
Operating Margin % -127.78
Pre-tax Margin (%) -173.40
Quick Ratio 3.22
Current Ratio 3.71
ROA % (ttm) -51.82
ROE % (ttm) -110.84
ROIC % (ttm) -68.00
Dividend Yield % --
Altman Z-Score -4.39
Piotroski F-Score 3.00
Positive ROA N
Positive CFROA N
Higher ROA y-y N
Cash flow > Earnings Y
Lower Leverage y-y N
Higher Current Ratio y-y N
Less Shares Outstanding y-y N
Gross Margin Increase y-y Y
Higher Asset Turnover y-y Y

TBIO Number of Guru Trades

To

TBIO Volume of Guru Trades

To

Gurus Latest Trades with NAS:TBIO

No Available Data

NAS:TBIO is held by these investors

No Available Data

Telesis Bio Inc Insider Transactions

No Available Data

News about NAS:TBIO

Total 0
  • 1